Last update:

Oncology & Cancer news

Oncology & Cancer

Hormone found to suppress immune cells, allowing cancer to evade detection

Researchers at UT Southwestern Medical Center have discovered how a hormone interacts with a receptor on the surface of immune cells to shield cancer cells from the body's natural defenses.

Oncology & Cancer

Plant virus triggers immune response that targets and destroys cancer cells

A virus that typically infects black-eyed peas is showing great promise as a low-cost, potent cancer immunotherapy—and researchers are uncovering why.

Oncology & Cancer

Chromatin organization linked to p53 tumor suppression mechanism

Each cell in our bodies carries about two meters of DNA in its nucleus, packed into a tiny volume of just a few hundred cubic micrometers—about a millionth of a milliliter. The cell manages this by winding the strings of ...

Oncology & Cancer

Key enzyme in cell migration and tumor metastasis identified

Konstanz researchers identify an enzyme that plays a role in the migration of cells in our body—not only during normal tissue formation and wound healing, but also when tumor cells metastasize. This makes the enzyme an ...

Oncology & Cancer

How inherited genes help shape the course of cancer

A new multicenter study by researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and colleagues around the world, has discovered that the ...

Medical research

New strategy may enable cancer monitoring from blood tests alone

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following treatment, according to a ...

Oncology & Cancer

New immune boost could expand access to cancer immunotherapy

Researchers at Moffitt Cancer Center have found that tapping into the body's own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of tumor-infiltrating lymphocyte, ...

Oncology & Cancer

Research reveals a hidden vulnerability of lung cancer

Treatment resistance and relapse in the most common type of lung cancer can be traced to a protein called agrin, according to a preclinical study led by Roswell Park Comprehensive Cancer Center. Results of the study, led ...

Medications

UK approves 'landmark' breast cancer drug

A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run National Health Service, officials said on Friday.

Oncology & Cancer

Master switch gene can turn immune cells into cancer eradicators

To grow, cancer tumors must hijack the immune system for their needs. One of the main tricks that most tumors use is to manipulate a type of immune cell called a macrophage, causing it to protect the tumor from the rest of ...

Oncology & Cancer

Scientists create 'metal detector' to hunt down tumors

Researchers have created a "metal detector" algorithm called PRRDetect to hunt down vulnerable tumors, in a development that could one day revolutionize the treatment of cancer.

Oncology & Cancer

A new drug delivery system may help patients with a rare eye cancer

A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may help patients with a rare eye cancer that has spread to their liver. This disease, ...